Quality Assurance

Focuses on validating software quality through test analysis, test case design, and test automation across web, API, and non-functional layers. Distinct from broader Software Engineering (which builds the product) and SRE/Platform reliability (which operates production infrastructure); this function owns risk-based test strategy, defect detection, automation frameworks, and quality outcomes against requirements throughout the SDLC.

22 leveled profiles. Pick a level to see the full profile.

Individual contributor

P1Quality Assurance — P1

Focuses on validating software quality through test analysis, test case design, and test automation across web, API, and non-functional layers. Distinct from broader Software Engineering (which builds the product) and SRE/Platform reliability (which operates production infrastructure); this function owns risk-based test strategy, defect detection, automation frameworks, and quality outcomes against requirements throughout the SDLC.

P1Quality Assurance - Biotechnology CDMO (GxP/Regulated) — P1

Quality Assurance for a biotechnology Contract Development and Manufacturing Organization (CDMO) operating in a GxP/regulated environment. Distinct from QC analytical testing focus (this is QA oversight of the quality system, not bench testing) and from in-house pharma QA in that it centers on CDMO-specific demands: client/sponsor quality interface, CMO oversight, quality agreements, batch disposition for multiple client products, and hosting client and regulatory inspections. Spans batch record review and disposition, deviation/investigation/CAPA/change control management, QMS ownership, supplier/CMO quality, and regulatory inspection readiness under cGxP, FDA, and ROW frameworks.

P2Quality Assurance - Life Sciences Robotics — P2

Quality engineering and computer system validation for integrated robotic laboratory automation in regulated life-sciences (GxP) environments. Distinct from general software QA in its grounding in GMP/GAMP 5 computer system validation, IQ/OQ/PQ qualification, and hardware-in-the-loop testing of fully integrated robotic workcells (liquid handlers, vision systems, PLCs); distinct from manufacturing/process QA in its focus on the automation software stack, test automation frameworks, and CI/CD-integrated quality gates across the robotics codebase. Spans configuration and unit testing of automation software through end-to-end QA ecosystem ownership and regulatory inspection leadership.

P2Quality Assurance — P2

Focuses on validating software quality through test analysis, test case design, and test automation across web, API, and non-functional layers. Distinct from broader Software Engineering (which builds the product) and SRE/Platform reliability (which operates production infrastructure); this function owns risk-based test strategy, defect detection, automation frameworks, and quality outcomes against requirements throughout the SDLC.

P2Quality Assurance - Biotechnology CDMO (GxP/Regulated) — P2

Quality Assurance for a biotechnology Contract Development and Manufacturing Organization (CDMO) operating in a GxP/regulated environment. Distinct from QC analytical testing focus (this is QA oversight of the quality system, not bench testing) and from in-house pharma QA in that it centers on CDMO-specific demands: client/sponsor quality interface, CMO oversight, quality agreements, batch disposition for multiple client products, and hosting client and regulatory inspections. Spans batch record review and disposition, deviation/investigation/CAPA/change control management, QMS ownership, supplier/CMO quality, and regulatory inspection readiness under cGxP, FDA, and ROW frameworks.

P3Quality Assurance - Life Sciences Robotics — P3

Quality engineering and computer system validation for integrated robotic laboratory automation in regulated life-sciences (GxP) environments. Distinct from general software QA in its grounding in GMP/GAMP 5 computer system validation, IQ/OQ/PQ qualification, and hardware-in-the-loop testing of fully integrated robotic workcells (liquid handlers, vision systems, PLCs); distinct from manufacturing/process QA in its focus on the automation software stack, test automation frameworks, and CI/CD-integrated quality gates across the robotics codebase. Spans configuration and unit testing of automation software through end-to-end QA ecosystem ownership and regulatory inspection leadership.

P3Quality Assurance — P3

Focuses on validating software quality through test analysis, test case design, and test automation across web, API, and non-functional layers. Distinct from broader Software Engineering (which builds the product) and SRE/Platform reliability (which operates production infrastructure); this function owns risk-based test strategy, defect detection, automation frameworks, and quality outcomes against requirements throughout the SDLC.

P3Quality Assurance - Biotechnology CDMO (GxP/Regulated) — P3

Quality Assurance for a biotechnology Contract Development and Manufacturing Organization (CDMO) operating in a GxP/regulated environment. Distinct from QC analytical testing focus (this is QA oversight of the quality system, not bench testing) and from in-house pharma QA in that it centers on CDMO-specific demands: client/sponsor quality interface, CMO oversight, quality agreements, batch disposition for multiple client products, and hosting client and regulatory inspections. Spans batch record review and disposition, deviation/investigation/CAPA/change control management, QMS ownership, supplier/CMO quality, and regulatory inspection readiness under cGxP, FDA, and ROW frameworks.

P4Quality Assurance - Life Sciences Robotics — P4

Quality engineering and computer system validation for integrated robotic laboratory automation in regulated life-sciences (GxP) environments. Distinct from general software QA in its grounding in GMP/GAMP 5 computer system validation, IQ/OQ/PQ qualification, and hardware-in-the-loop testing of fully integrated robotic workcells (liquid handlers, vision systems, PLCs); distinct from manufacturing/process QA in its focus on the automation software stack, test automation frameworks, and CI/CD-integrated quality gates across the robotics codebase. Spans configuration and unit testing of automation software through end-to-end QA ecosystem ownership and regulatory inspection leadership.

P4Quality Assurance - Biotechnology CDMO (GxP/Regulated) — P4

Quality Assurance for a biotechnology Contract Development and Manufacturing Organization (CDMO) operating in a GxP/regulated environment. Distinct from QC analytical testing focus (this is QA oversight of the quality system, not bench testing) and from in-house pharma QA in that it centers on CDMO-specific demands: client/sponsor quality interface, CMO oversight, quality agreements, batch disposition for multiple client products, and hosting client and regulatory inspections. Spans batch record review and disposition, deviation/investigation/CAPA/change control management, QMS ownership, supplier/CMO quality, and regulatory inspection readiness under cGxP, FDA, and ROW frameworks.

P4Quality Assurance — P4

Focuses on validating software quality through test analysis, test case design, and test automation across web, API, and non-functional layers. Distinct from broader Software Engineering (which builds the product) and SRE/Platform reliability (which operates production infrastructure); this function owns risk-based test strategy, defect detection, automation frameworks, and quality outcomes against requirements throughout the SDLC.

P5Quality Assurance — P5

Focuses on validating software quality through test analysis, test case design, and test automation across web, API, and non-functional layers. Distinct from broader Software Engineering (which builds the product) and SRE/Platform reliability (which operates production infrastructure); this function owns risk-based test strategy, defect detection, automation frameworks, and quality outcomes against requirements throughout the SDLC.

P5Quality Assurance - Biotechnology CDMO (GxP/Regulated) — P5

Quality Assurance for a biotechnology Contract Development and Manufacturing Organization (CDMO) operating in a GxP/regulated environment. Distinct from QC analytical testing focus (this is QA oversight of the quality system, not bench testing) and from in-house pharma QA in that it centers on CDMO-specific demands: client/sponsor quality interface, CMO oversight, quality agreements, batch disposition for multiple client products, and hosting client and regulatory inspections. Spans batch record review and disposition, deviation/investigation/CAPA/change control management, QMS ownership, supplier/CMO quality, and regulatory inspection readiness under cGxP, FDA, and ROW frameworks.

P5Quality Assurance - Life Sciences Robotics — P5

Quality engineering and computer system validation for integrated robotic laboratory automation in regulated life-sciences (GxP) environments. Distinct from general software QA in its grounding in GMP/GAMP 5 computer system validation, IQ/OQ/PQ qualification, and hardware-in-the-loop testing of fully integrated robotic workcells (liquid handlers, vision systems, PLCs); distinct from manufacturing/process QA in its focus on the automation software stack, test automation frameworks, and CI/CD-integrated quality gates across the robotics codebase. Spans configuration and unit testing of automation software through end-to-end QA ecosystem ownership and regulatory inspection leadership.

P6Quality Assurance — P6

Focuses on validating software quality through test analysis, test case design, and test automation across web, API, and non-functional layers. Distinct from broader Software Engineering (which builds the product) and SRE/Platform reliability (which operates production infrastructure); this function owns risk-based test strategy, defect detection, automation frameworks, and quality outcomes against requirements throughout the SDLC.

P6Quality Assurance - Life Sciences Robotics — P6

Quality engineering and computer system validation for integrated robotic laboratory automation in regulated life-sciences (GxP) environments. Distinct from general software QA in its grounding in GMP/GAMP 5 computer system validation, IQ/OQ/PQ qualification, and hardware-in-the-loop testing of fully integrated robotic workcells (liquid handlers, vision systems, PLCs); distinct from manufacturing/process QA in its focus on the automation software stack, test automation frameworks, and CI/CD-integrated quality gates across the robotics codebase. Spans configuration and unit testing of automation software through end-to-end QA ecosystem ownership and regulatory inspection leadership.

P6Quality Assurance - Biotechnology CDMO (GxP/Regulated) — P6

Quality Assurance for a biotechnology Contract Development and Manufacturing Organization (CDMO) operating in a GxP/regulated environment. Distinct from QC analytical testing focus (this is QA oversight of the quality system, not bench testing) and from in-house pharma QA in that it centers on CDMO-specific demands: client/sponsor quality interface, CMO oversight, quality agreements, batch disposition for multiple client products, and hosting client and regulatory inspections. Spans batch record review and disposition, deviation/investigation/CAPA/change control management, QMS ownership, supplier/CMO quality, and regulatory inspection readiness under cGxP, FDA, and ROW frameworks.

Management

M1Quality Assurance & Control (General) — M1

Management of quality assurance and quality control operations spanning inspection, testing, and validation across both manufacturing/product-quality (metrology, SPC, CAPA, QMS standards) and software/test-engineering (test automation, release validation, test architecture) domains. Distinct from sibling focuses such as Regulatory/Compliance Affairs, Supplier Quality, or Reliability Engineering — this focus owns the day-to-day quality control systems, inspection/test teams, defect prevention, and quality signal ownership that gate production and release.

M2Quality Assurance & Control (General) — M2

Management of quality assurance and quality control operations spanning inspection, testing, and validation across both manufacturing/product-quality (metrology, SPC, CAPA, QMS standards) and software/test-engineering (test automation, release validation, test architecture) domains. Distinct from sibling focuses such as Regulatory/Compliance Affairs, Supplier Quality, or Reliability Engineering — this focus owns the day-to-day quality control systems, inspection/test teams, defect prevention, and quality signal ownership that gate production and release.

M3Quality Assurance & Control (General) — M3

Management of quality assurance and quality control operations spanning inspection, testing, and validation across both manufacturing/product-quality (metrology, SPC, CAPA, QMS standards) and software/test-engineering (test automation, release validation, test architecture) domains. Distinct from sibling focuses such as Regulatory/Compliance Affairs, Supplier Quality, or Reliability Engineering — this focus owns the day-to-day quality control systems, inspection/test teams, defect prevention, and quality signal ownership that gate production and release.

M4Quality Assurance & Control (General) — M4

Management of quality assurance and quality control operations spanning inspection, testing, and validation across both manufacturing/product-quality (metrology, SPC, CAPA, QMS standards) and software/test-engineering (test automation, release validation, test architecture) domains. Distinct from sibling focuses such as Regulatory/Compliance Affairs, Supplier Quality, or Reliability Engineering — this focus owns the day-to-day quality control systems, inspection/test teams, defect prevention, and quality signal ownership that gate production and release.

M5Quality Assurance & Control (General) — M5

Management of quality assurance and quality control operations spanning inspection, testing, and validation across both manufacturing/product-quality (metrology, SPC, CAPA, QMS standards) and software/test-engineering (test automation, release validation, test architecture) domains. Distinct from sibling focuses such as Regulatory/Compliance Affairs, Supplier Quality, or Reliability Engineering — this focus owns the day-to-day quality control systems, inspection/test teams, defect prevention, and quality signal ownership that gate production and release.